CN101816386B - Konjak oligosaccharide buccal tablets - Google Patents
Konjak oligosaccharide buccal tablets Download PDFInfo
- Publication number
- CN101816386B CN101816386B CN201010140154A CN201010140154A CN101816386B CN 101816386 B CN101816386 B CN 101816386B CN 201010140154 A CN201010140154 A CN 201010140154A CN 201010140154 A CN201010140154 A CN 201010140154A CN 101816386 B CN101816386 B CN 101816386B
- Authority
- CN
- China
- Prior art keywords
- konjak
- oligosaccharide
- buccal tablets
- percent
- glucomannan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to konjak oligosaccharide buccal tablets, which belong to the technical field of food processing. The konjak oligosaccharide buccal tablets are prepared by a method comprising the following steps of: dissolving konjak glucomannan containing 85 percent of glucomannan in water with stirring according to a principle that 10 grams of the konjak glucomannan is dissolved in each 100 mL of water; adding a mixture of mannase, cellulose and hemicellulase into the konjak glucomannan based on a principle that 1 gram of the konjak glucomannan is added with 200 to 300 mu enzymatic activity units, wherein the enzymatic activity ratio in the mixture is 5:1:1; performing thermal-insulation hydrolysis at the temperature of between 30 and 50 DEG C for 4 to 6 hours; heating the hydrolysis solution to boil the hydrolysis solution for 10 minutes; stopping the enzymolysis; subjecting the reaction solution to centrifugation and filtration sequentially; filtering the manna oligosaccharide mixed liquid with a membrane and concentrating the mixed liquid under a reduced pressure to obtain manna oligosaccharide mixed liquid; dissolving 0.05 to 0.08 percent of aspartame, 10 to 15 percent of xylitol, 15 to 20 percent of olive extract powder, 10 to 40 percent of maltodextrin and 10 to 15 percent of starch into the manna oligosaccharide mixed liquid sequentially; drying to the mixture to obtain konjak oligosaccharide powder; and tabletting the konjak oligosaccharide powder to obtain the konjak oligosaccharide buccal tablets. The konjak oligosaccharide buccal tablets have the advantages of uniform taste and color, good mouthfeel, outstanding flavor, edible convenience and good health-care effect. The konjak oligosaccharide buccal tablets are particularly suitable for industrialized production.
Description
Technical field:
The present invention relates to a kind of konjak oligosaccharide buccal tablets, belong to food processing technology field.
Background technology:
Konjak oligosaccharide is to be raw material with the konjac glucomannan, under the effect of mannase, makes through hydrolysis.The number average relative molecular mass of konjac oligosaccharides is 5300 behind the enzymolysis, and average weight-molecular mass is 3160.Konjac glucomannan is from Araeceae Amorphophallus (Amorphophallus Blume) plant, extracts in the konjak corm and gets, and be a kind of macromolecule polysaccharide.Molecule is polymerized through β-1,4 glycosidic bond by the glucose and the mannose residue of 1: 1.6 or 1: 1.7, and molecule is 20～2,000,000.Show konjak oligosaccharide to promoting bifidobacterium growth very effective according to zoopery and clinical research, and can improve the gut flora structure effectively, and its performance and effect are superior to lactulose, soyabean oligosaccharides and galactosyl and shift compound sugar.Konjak oligosaccharide also has effects such as the hypertension of control, reducing blood lipid, anti-oxidant, fat-reducing, raise immunity.Can effectively remove hydroxy radical (.OH); Mouse is added konjak oligosaccharide in right amount is of value to the oxidation resistance that improves liver organization, and the protection liver is avoided various oxidative stress and damage.
Through the document retrieval, do not see the public reported identical with the present invention.
Summary of the invention:
The object of the present invention is to provide to be particularly suitable for high fat of blood, hyperglycaemia, obese people is edible, has a kind of konjak oligosaccharide buccal tablets of easy to use, instant, good health care effect.
Konjak oligosaccharide buccal tablets of the present invention obtains through following method:
A. the konjac glucomannan of Glucomannan content 85% is pressed 10g/100mL water elder generation stirring and dissolving; Press konjac glucomannan 1g: 200-300u enzyme unit alive drops into mannase, cellulase, hemicellulose enzymatic mixture, and the enzyme ratio of living is 5: 1: 1 in mannase, cellulase, the hemicellulose enzymatic mixture; Be incubated hydrolysis 4-6 hour down at 30-50 ℃, be heated to boiling 10 minutes, enzymolysis reaction adopts centrifugal filtration then successively, obtains manna oligosacchride mixed liquor and filter residue; The manna oligosacchride mixed liquor removes big molecule and insoluble matter through membrane filtration, and filtrating is 30-40% through being evaporated to manna oligosacchride content, promptly obtains the manna oligosacchride mixed liquor made from extra care;
B. will be for the Aspartame of 0.05-0.08%, the xylitol of 10-15%, the olive extraction powder of 15-20%, the maltodextrin of 10-40%, the starch of 10-15% to dissolve in the refining manna oligosacchride mixed liquor successively, spray-drying obtains the konjak oligosaccharide powder of seasoning after the stirring and dissolving;
C. the konjak oligosaccharide powder that modulates is carried out compressing tablet by conventional method, promptly get konjak oligosaccharide buccal tablets.
Used ratio is g/100mL among the preparation method of konjak oligosaccharide buccal tablets of the present invention.
The konjak oligosaccharide buccal tablets that the present invention obtains has taste and color and luster is even, sweet and sour taste, and slightly acid that the inlet flavour is fresh and sweet, it is sweet good to return, and local flavor is outstanding, instant, the advantage of good health care effect.Be particularly suitable for industrialization production.
The specific embodiment:
Konjak oligosaccharide buccal tablets of the present invention adopts conventional common apparatus to obtain through following method:
A. the konjac glucomannan of Glucomannan content 85% is pressed 10g/100mL water elder generation stirring and dissolving; Press konjac glucomannan 1g: 200 250 or the 300u enzyme unit that lives drop into mannase, cellulase, hemicellulose enzymatic mixture, the enzyme ratio of living is 5: 1: 1 in mannase, cellulase, the hemicellulose enzymatic mixture; 30 or 40 or 50 ℃ of down insulation hydrolysis 4 or 5 or 6 hours, be heated to boiling 10 minutes, enzymolysis reaction adopts link-suspended basket centrifuge centrifugal filtration then successively, obtains manna oligosacchride mixed liquor and filter residue; Manna oligosacchride mixed liquor via hole diameter is 0.45 micron a membrane filtration, removes big molecule and insoluble matter, and it is 30% or 35% or 40% that filtrating uses conventional method to be evaporated to manna oligosacchride content, promptly obtains the manna oligosacchride mixed liquor made from extra care;
B. auxiliary material Aspartame (0.05% or 0.06 or 0.08%), xylitol (10% or 12% or 15%), olive extraction powder (15% or 18% or 20%), maltodextrin (10% or 25% or 40%), starch (10% or 13% or 15%) are fully dissolved in the refining manna oligosacchride mixed liquor successively, spray-drying obtains the konjak oligosaccharide powder of seasoning after the stirring and dissolving;
C. the konjak oligosaccharide powder that modulates is carried out compressing tablet by the method for routine, promptly get konjak oligosaccharide buccal tablets.
The content of konjak oligosaccharide buccal tablet of the present invention is (calculating with 100g): oligosaccharides powder 20-35%, Aspartame 0.05-0.08%, xylitol 10-15%, olive extraction powder 15-20%, starch 10-15%, maltodextrin 10-40%.
Used ratio is g/100mL among the above-mentioned preparation method.
Konjak oligosaccharide buccal tablet of the present invention is light yellow, slightly acid that the inlet flavour is fresh and sweet, and it is sweet good to return, and local flavor is outstanding, and sliding suitable, the no particle of inlet and the sense of eking out a living, edible collapsing property are good, suit the taste of both old and young, and are particularly suitable for high fat of blood, hyperglycaemia, and obese people eats.Konjak oligosaccharide buccal tablet instant, good health care effect.
Claims (1)
1. konjak oligosaccharide buccal tablets is characterized in that konjak oligosaccharide buccal tablets obtains through following method:
A. the konjac glucomannan of Glucomannan content 85% is pressed 10g/100mL water elder generation stirring and dissolving; Press konjac glucomannan 1g: 200-300u enzyme unit alive drops into mannase, cellulase, hemicellulose enzymatic mixture, and the enzyme ratio of living is 5: 1: 1 in mannase, cellulase, the hemicellulose enzymatic mixture; Be incubated hydrolysis 4-6 hour down at 30-50 ℃, be heated to boiling 10 minutes, enzymolysis reaction adopts centrifugal filtration then successively, obtains manna oligosacchride mixed liquor and filter residue; The manna oligosacchride mixed liquor removes big molecule and insoluble matter through membrane filtration, and filtrating is 30-40% through being evaporated to manna oligosacchride content, promptly obtains the manna oligosacchride mixed liquor made from extra care;
B. the Aspartame of 0.05-0.08%, the xylitol of 10-15%, the olive extraction powder of 15-20%, the maltodextrin of 10-40%, the starch of 10-15% are dissolved in the refining manna oligosacchride mixed liquor successively, spray-drying obtains the konjak oligosaccharide powder of seasoning after the stirring and dissolving;
C. the konjak oligosaccharide powder that modulates is carried out compressing tablet by conventional method, promptly get konjak oligosaccharide buccal tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010140154A CN101816386B (en) | 2010-04-07 | 2010-04-07 | Konjak oligosaccharide buccal tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010140154A CN101816386B (en) | 2010-04-07 | 2010-04-07 | Konjak oligosaccharide buccal tablets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101816386A CN101816386A (en) | 2010-09-01 |
| CN101816386B true CN101816386B (en) | 2012-10-10 |
Family
ID=42651789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010140154A Expired - Fee Related CN101816386B (en) | 2010-04-07 | 2010-04-07 | Konjak oligosaccharide buccal tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816386B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102894250A (en) * | 2012-10-18 | 2013-01-30 | 华东理工大学 | Composition and application of composition to hypoglycemic food |
| CN104642966A (en) * | 2015-03-17 | 2015-05-27 | 武俐宏 | Using and preparation methods of konjak vitamin powder |
| CN106136232A (en) * | 2016-06-30 | 2016-11-23 | 成都永安缘和生物科技有限公司 | A kind of preparation method of beneficial bacteria factor composite chewable tablet |
| CN109275770A (en) * | 2018-06-25 | 2019-01-29 | 聂菲菲 | A kind of konjak oligosaccharide buccal tablets |
| CN109156828A (en) * | 2018-08-10 | 2019-01-08 | 广州钮和生物科技有限公司 | A kind of drink and preparation method with lower blood-fat and reduce weight function |
| CN109811022B (en) * | 2019-03-28 | 2020-07-07 | 南京益纤生物科技有限公司 | Preparation method and application of galactomannan oligosaccharide |
| CN111513273A (en) * | 2020-04-01 | 2020-08-11 | 陕西理工大学 | Konjak functional food and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1339299A (en) * | 2001-10-09 | 2002-03-13 | 赵因 | Method for preparing medicine for urogenital system |
| CN1947770A (en) * | 2005-10-12 | 2007-04-18 | 云南省天然药物中心 | Medicinal composition with wt.-reducing function |
| CN100510094C (en) * | 2006-05-29 | 2009-07-08 | 湖北广华生物有限公司 | Production method of konjak mannose using cellulase |
| CN101617800A (en) * | 2008-06-30 | 2010-01-06 | 昆明格林斯通生物工程有限公司 | Fructus phyllanthi buccal tablet and preparation method thereof |
-
2010
- 2010-04-07 CN CN201010140154A patent/CN101816386B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 王爱华等.浅谈甘露低聚糖的保健功能及应用.《安徽农业科学》.2006,第34卷(第13期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101816386A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816386B (en) | Konjak oligosaccharide buccal tablets | |
| Vázquez et al. | Xylooligosaccharides: manufacture and applications | |
| JP2008501321A5 (en) | ||
| CN103385515B (en) | Plant drink and preparation method thereof | |
| CN108720030B (en) | Dietary fiber composition for targeted improvement of metabolic syndrome | |
| US10632136B2 (en) | Soluble dietary fiber and preparation method thereof | |
| KR102381709B1 (en) | Method of manufacuring dietary fiber | |
| CN1826976A (en) | Extraction of dietary fiber of bitter melon and method for preparing health-caring food by utilizing dietary fiber of bitter melon | |
| CN106947006B (en) | A kind of production method of high-purity inulin | |
| WO2020259098A1 (en) | Green preparation method for soluble and insoluble dietary fibers in fruit and vegetable residues | |
| CN106749750A (en) | A kind of preparation method of highland barley grain beta glucan | |
| CN104957586A (en) | Multi-plant fiber salt and preparation method for same | |
| CN108359026A (en) | A kind of preparation method and its usage of water-insoluble xylan | |
| CN101731509A (en) | Method for extracting inulin from Canada potato | |
| CN106947000B (en) | A kind of preparation method of high-purity polyfructosan | |
| CN105647993A (en) | Production technology of liquid oligogalacturonic acid pectin | |
| KR101566773B1 (en) | Composition for Ginseng Jelly without Sugar and Manufacturing Method Thereof | |
| CN105559038B (en) | A kind of preparation method of starch base dietary fiber | |
| CN109275770A (en) | A kind of konjak oligosaccharide buccal tablets | |
| CN106399425A (en) | Method using activated carbon absorption and ethanol desorption to synchronously produce different-quality xylooligosaccharide | |
| CN108165592B (en) | Method for extracting inulin by using mesoporous material immobilized complex enzyme | |
| CN107912758B (en) | Preparation method of drying-promoting and moisture-absorption-resisting composite functional xylo-oligosaccharide composition | |
| KR101929664B1 (en) | Fermented-white ginseng extracts containing increased ginsenoside Rd, Rg3 and Rg5 and method thereof | |
| CN111602736A (en) | Preparation method of composite modified dietary fiber soft sweets | |
| KR20200126207A (en) | Enzymatic lysate of phaeophyceae with enhanced alginate content and method for preparing thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121010 Termination date: 20130407 |